Journal article
Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization
Abstract
BACKGROUND: The VOYAGER PAD trial (Vascular Outcomes Study of ASA Along With Rivaroxaban in Endovascular or Surgical Limb Revascularization for Peripheral Artery Disease) demonstrated superiority of rivaroxaban plus aspirin versus aspirin to reduce major cardiac and ischemic limb events after lower extremity revascularization. Clopidogrel is commonly used as a short-term adjunct to aspirin after endovascular revascularization. Whether …
Authors
Hiatt WR; Bonaca MP; Patel MR; Nehler MR; Debus ES; Anand SS; Capell WH; Brackin T; Jaeger N; Hess CN
Journal
Circulation, Vol. 142, No. 23, pp. 2219–2230
Publisher
Wolters Kluwer
Publication Date
December 8, 2020
DOI
10.1161/circulationaha.120.050465
ISSN
0009-7322